SCHEMBL4649660

SCHEMBL4649660

O=C(C1CCCNC1)N1CCN(c2ccc(Cl)c(Cl)c2)CC1.O=C([C@H]1CCCN(C2CC2)C1)N1CCN(c2ccc(Cl)c(Cl)c2)CC1

nearest known ligand 0.47

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
KHK P50053 1/20 0.47
KMT2A Q03164 1/20 0.45
CCR4 P51679 1/20 0.44
CCR2 P41597 3/20 0.43
KCNH2 Q12809 3/20 0.43
GFER P55789 1/20 0.43
NOTUM Q6P988 2/20 0.42
MAPT P10636 2/20 0.42
SMN1; SMN2 Q16637 2/20 0.42
DPP4 P27487 1/20 0.42
L3MBTL1 Q9Y468 1/20 0.42
LMNA P02545 2/20 0.41
MAPK1 P28482 2/20 0.41
ALDH1A1 P00352 1/20 0.41
HTT P42858 2/20 0.41
ENPP2 Q13822 1/20 0.41
CYP3A4 P08684 1/20 0.41
CYP2D6 P10635 1/20 0.41
ADRB1 P08588 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1778652 0.91 KMT2A (0.52) KMT2ACCR2KCNH2GFERNOTUM
SCHEMBL1779767 0.91 KHK (0.54) KHKKMT2ACCR4CCR2KCNH2
SCHEMBL1777518 0.91 KMT2A (0.52) KMT2ACCR2KCNH2GFERNOTUM
SCHEMBL1779768 0.91 KHK (0.54) KHKKMT2ACCR4CCR2KCNH2
SCHEMBL1779017 0.78 L3MBTL1 (0.56) KMT2ACCR2KCNH2GFERNOTUM
SCHEMBL1778633 0.77 CCR2 (0.69) KMT2ACCR2KCNH2NOTUMMAPT
SCHEMBL1779516 0.77 KMT2A (0.53) KMT2AGFERNOTUMMAPTSMN1; SMN2
SCHEMBL1778164 0.76 CCR2 (0.64) CCR2KCNH2NOTUMMAPTSMN1; SMN2
SCHEMBL1777773 0.75 CCR2 (0.63) CCR2KCNH2NOTUMMAPTSMN1; SMN2
SCHEMBL24324251 0.74 MAPT (0.55) KHKKMT2AMAPTSMN1; SMN2L3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1966187-A1 PIPERAZINE COMPOUNDS USEFUL AS ANTAGONISTS OF C-C CHEMOKINES (CCR2B AND CCR5) FOR THE TREATMENT OF INFLAMMATORY DISEASES AstraZeneca AB (SE) 2008-09-10 EP disclosed
WO-2007071952-A1 PIPERAZINE COMPOUNDS USEFUL AS ANTAGONISTS OF C-C CHEMOKINES (CCR2B AND CCR5) FOR THE TREATMENT OF INFLAMMATORY DISEASES ASTRAZENECA AB (SE) 2007-06-28 WO disclosed